A SECRET WEAPON FOR SEMAGLUTIDE WEEK 1-6 BUNDLE

The trial attained both of those its Most important endpoints, with semaglutide 2.four mg demonstrating statistically significant and exceptional improvements in liver fibrosis with no worsening of steatohepatitis, together with resolution of steatohepatitis with no worsening of liver fibrosis in individuals with MASH compared to placebo.1Mumsnet h